✦ LIBER ✦

Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)

✍ Scribed by Azra Raza, Naomi Galili, Deborah Mulford, Scott E Smith, Gail L Brown, David P Steensma, Roger M Lyons, Ralph Boccia, Mikkael A Sekeres, Guillermo Garcia-Manero, Ruben A Mesa

Book ID: 119913610
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 203 KB
Volume: 5
Category: Article
ISSN: 1756-8722
DOI: 10.1186/1756-8722-5-18

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lenalidomide is active in Japanese patie

Lenalidomide is active in Japanese patients with symptomatic anemia in low- or intermediate-1 risk myelodysplastic syndromes with a deletion 5q abnormality

✍ Hironori Harada; Mitsumasa Watanabe; Kenshi Suzuki; Soshi Yanagita; Takahiro Suz 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 228 KB

Lenalidomide: A Review of its Use in Pat

Lenalidomide: A Review of its Use in Patients with Transfusion-Dependent Anaemia due to Low- or Intermediate-1-Risk Myelodysplastic Syndrome Associated with 5q Chromosome Deletion

✍ Syed, Yahiya Y.; Scott, Lesley J. 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 486 KB

Health-related quality of life outcomes

✍ Revicki, Dennis A.; Brandenburg, Nancy A.; Muus, Petra; Yu, Ren; Knight, Robert; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 321 KB

Phase 1-2a multicenter dose-escalation s

Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra®, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome

✍ Azra Raza; Naomi Galili; Natalie Callander; Leonel Ochoa; Lawrence Piro; Peter E 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 246 KB

Phase II study of the histone deacetylas

Phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in patients with low or intermediate-1 risk myelodysplastic syndrome

✍ Sophie Dimicoli; Elias Jabbour; Gautam Borthakur; Tapan Kadia; Zeev Estrov; Hui 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 850 KB

Lenalidomide in International Prognostic

Lenalidomide in International Prognostic Scoring System Low and Intermediate-1 risk myelodysplastic syndromes with del(5q): an Italian phase II trial of health-related quality of life, safety and efficacy

✍ Oliva, Esther N.; Latagliata, Roberto; Laganà, Carmelo; Breccia, Massimo; Galimb 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 564 KB